CoChat

Mesenchymal Stem Cells Loaded in Injectable Alginate Hydrogels Promote Liver Growth and Attenuate Liver Fibrosis in Cirrhotic Rats

Open access

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.

Abstract

Cirrhosis, a marker of severe liver diseases, limits future liver remnant (FLR) growth, preventing many cancer patients from undergoing surgery. While portal vein blockade (PVB) techniques are used to stimulate liver regeneration, 20–30% of patients still fail to achieve the required growth. Although mesenchymal stem cell (MSC) therapy improves PVB, its efficacy is limited by poor cell retention. To address this, we utilized alginate hydrogels to deliver MSCs and improve their retention. MSCs were loaded in the hydrogel and injected intraportally in cirrhotic rats. Liver volume, weights, enzyme levels, and histology were monitored. Results showed that the hydrogel maintained 89.0 ± 3.0% cell viability and gradually released MSCs for over two weeks. Furthermore, the rats injected with the MSC-loaded hydrogel demonstrated higher liver volumes (FLR ratio of 0.57 ± 0.32) and weights (FLR ratio of 0.84 ± 0.05). The treated rats exhibited more improved liver enzymes (AST: 72.75 ± 14.17 U/L, ALP: 135.67 ± 41.20 U/L, ALT: 46.00 ± 2.94 U/L) and decreased fibrotic areas in the liver (4.52 ± 0.22%) compared to the control group. Histology revealed increased retention when MSCs were delivered with the hydrogel (37.30 ± 16.10 MSCs/mm2) compared to cells alone (21.70 ± 22.10 MSCs/mm2). Overall, the MSC-loaded hydrogels enhanced the growth and reduced the fibrosis of the liver by promoting cell retention and efficacy in cirrhotic rats. This approach holds significant potential for improving outcomes among cancer patients, offering a promising therapeutic strategy for liver regeneration and treatment of liver diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/gels11040250

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Characterization of MSC-loaded hydrogels. (a) Brightfield (left), fluorescence (middle), and overlay (right) images from microscopy show wide distribution of RFP-MSCs (black arrows) within the hydrogel scaffold. (b) Viability of the MSCs was maintained after loading in hydrogels (quantified through trypan blue staining). (c) MSCs were gradually released over 14 days. Abbreviations: RFP-MSCs, red fluorescent protein–mesenchymal stem cells.
Figure 1 Characterization of MSC-loaded hydrogels. (a) Brightfield (left), fluorescence (middle), and overlay (right) images from microscopy show wide distribution of RFP-MSCs (black arrows) within the hydrogel scaffold. (b) Viability of the MSCs was maintained after loading in hydrogels (quantified through trypan blue staining). (c) MSCs were gradually released over 14 days. Abbreviations: RFP-MSCs, red fluorescent protein–mesenchymal stem cells.CC BY · PubMed Central
Figure 2 Functional and histologic changes in cirrhotic rat models. (a) Serum chemistry levels of liver damage markers (AST, ALT, and LDH) and synthetic function (albumin) showed a significant increase after induction of cirrhosis. (b–d) Trichrome staining of liver samples from (b) control vs. (c) cirrhotic rats showing increase in the collagen staining and fibrosis (d) Abbreviations: AST, aspartate aminotransferase; ALT, alanine aminotransferase; LDH, lactate dehydrogenase; ** p < 0.01.
Figure 2 Functional and histologic changes in cirrhotic rat models. (a) Serum chemistry levels of liver damage markers (AST, ALT, and LDH) and synthetic function (albumin) showed a significant increase after induction of cirrhosis. (b–d) Trichrome staining of liver samples from (b) control vs. (c) cirrhotic rats showing increase in the collagen staining and fibrosis (d) Abbreviations: AST, aspartate aminotransferase; ALT, alanine aminotransferase; LDH, lactate dehydrogenase; ** p < 0.01.CC BY · PubMed Central
Figure 3 Future liver remnant (FLR) growth by CT volume and weight in CCl4-treated rats. (a) CT imaging showed an increase in FLR volume (yellow) relative to total liver volume (violet) in the treatment groups, with greatest growth observed in the MSC-loaded hydrogel group. Visual inspection of the gross livers also showed notable increase in FLR in the MSC-loaded hydrogel group compared to the control. To assess the degree of growth, the FLR-to-total liver ratio was quantified by both volume (b) and by weight (c) across the different treatment groups. ** p < 0.01; *** p < 0.001. Abbreviations: Alg, alginate; CT, computed tomography; FLR, future liver remnant; MSC, mesenchymal stem cell; PVL, portal vein ligation.
Figure 3 Future liver remnant (FLR) growth by CT volume and weight in CCl4-treated rats. (a) CT imaging showed an increase in FLR volume (yellow) relative to total liver volume (violet) in the treatment groups, with greatest growth observed in the MSC-loaded hydrogel group. Visual inspection of the gross livers also showed notable increase in FLR in the MSC-loaded hydrogel group compared to the control. To assess the degree of growth, the FLR-to-total liver ratio was quantified by both volume (b) and by weight (c) across the different treatment groups. ** p < 0.01; *** p < 0.001. Abbreviations: Alg, alginate; CT, computed tomography; FLR, future liver remnant; MSC, mesenchymal stem cell; PVL, portal vein ligation.CC BY · PubMed Central
Figure 4 Serum chemistry levels of liver function markers among different treatment groups. The levels of AST, ALP, and ALT that are indicative of liver injury were reduced. Meanwhile, LDH and albumin levels were comparable among the different treatment groups. Abbreviations: PVL, portal vein ligation; AST, aspartate aminotransferase; ALP, alkaline phosphatase; ALT, alanine aminotransferase; LDH, lactate dehydrogenase; * p < 0.05.
Figure 4 Serum chemistry levels of liver function markers among different treatment groups. The levels of AST, ALP, and ALT that are indicative of liver injury were reduced. Meanwhile, LDH and albumin levels were comparable among the different treatment groups. Abbreviations: PVL, portal vein ligation; AST, aspartate aminotransferase; ALP, alkaline phosphatase; ALT, alanine aminotransferase; LDH, lactate dehydrogenase; * p < 0.05.CC BY · PubMed Central
Figure 5 The effect of MSC-loaded hydrogels on collagen deposition in the liver. (a) Masson’s trichrome staining of the livers among the treatment groups showed reduction in the degree of fibrosis. (b) Quantification of the fibrotic areas through image analysis software revealed significant reduction in areas of fibrosis after MSC treatment. Abbreviations: Alg, alginate; MSC, mesenchymal stem cell; PVL, portal vein ligation; * p < 0.05; ** p < 0.01.
Figure 5 The effect of MSC-loaded hydrogels on collagen deposition in the liver. (a) Masson’s trichrome staining of the livers among the treatment groups showed reduction in the degree of fibrosis. (b) Quantification of the fibrotic areas through image analysis software revealed significant reduction in areas of fibrosis after MSC treatment. Abbreviations: Alg, alginate; MSC, mesenchymal stem cell; PVL, portal vein ligation; * p < 0.05; ** p < 0.01.CC BY · PubMed Central
Figure 6 Immunohistochemistry staining of red fluorescent protein (RFP)-positive cells in the liver. (a) Tissue sections of rat livers treated with MSCs only (top) and MSC-loaded hydrogels (bottom) showed the presence of RFP+ cells in the periportal areas (black arrows). (b) Quantification of RFP+ cells demonstrated an increase in the number of RFP+ cells in groups treated with PVL+MSC-Alg (p = 0.0658). Abbreviations: Alg, alginate; MSC, mesenchymal stem cell; PVL, portal vein ligation; RFP, red fluorescent protein.
Figure 6 Immunohistochemistry staining of red fluorescent protein (RFP)-positive cells in the liver. (a) Tissue sections of rat livers treated with MSCs only (top) and MSC-loaded hydrogels (bottom) showed the presence of RFP+ cells in the periportal areas (black arrows). (b) Quantification of RFP+ cells demonstrated an increase in the number of RFP+ cells in groups treated with PVL+MSC-Alg (p = 0.0658). Abbreviations: Alg, alginate; MSC, mesenchymal stem cell; PVL, portal vein ligation; RFP, red fluorescent protein.CC BY · PubMed Central
Figure 7 Summary of the study. The therapeutic potential of mesenchymal stem cells (MSCs) is hindered by rapid washout of cells in the liver. In this study, MSCs were loaded in injectable hydrogels and delivered in vivo. Upon injection of hydrogels, MSCs had increased retention and efficacy, which led to enhanced liver growth and attenuation of fibrosis (created with Biorender.com). Abbreviations: MSC, mesenchymal stem cell.
Figure 7 Summary of the study. The therapeutic potential of mesenchymal stem cells (MSCs) is hindered by rapid washout of cells in the liver. In this study, MSCs were loaded in injectable hydrogels and delivered in vivo. Upon injection of hydrogels, MSCs had increased retention and efficacy, which led to enhanced liver growth and attenuation of fibrosis (created with Biorender.com). Abbreviations: MSC, mesenchymal stem cell.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 66 references

Cited by

See all 20

Metadata

Authors
Bolinas, D. K. M., Barcena, A. J. R., Mishra, A., Bernardino, M. R., Lin, V., Heralde, F. M., Chintalapani, G., Fowlkes, N. W., Huang, S. Y., & Melancon, M. P.
Affiliations
  • The University of Texas MD Anderson Cancer Center (US)
  • University of the Philippines Manila (PH)
Corresponding author
Melancon, Marites P.
Venue
Gels
Publisher
MDPI AG
Published
2025-03-27
Volume
11
Issue
4
Pages
250
ISSN
2310-2861 (ISSN-L)
OpenAlex
W4408928598
Cited by
20
References
66
Citations by year
2026: 16 · 2025: 4
FWCI
12.85
Type
journal article
Language
en
Open access
Locations
  • Gels (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Digital Commons-TMC (Texas Medical Center) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institutes of Health—National Cancer Institute (P30CA016672, R25 CA-265800-01A1)
  • Joint Center for Computational Oncology (JCCO) Pilot Grant (P30CA016672, R25 CA-265800-01A1)
  • Department of Science and Technology-Philippine Council for Health Research and Development (P30CA016672, R25 CA-265800-01A1)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
Keywords
mesenchymal stem cells, alginate hydrogel, liver cirrhosis, liver regeneration, liver fibrosis, cell retention, future liver remnant, liver cancer surgery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mesenchymal Stem Cells Loaded in Injectable Alginate Hydrogels Promote Liver Growth and Attenuate Liver Fibrosis in Cirrhotic Rats. https://app.cochat.ai/papers/10.3390/gels11040250
The paper
Bolinas, D. K. M., Barcena, A. J. R., Mishra, A., Bernardino, M. R., Lin, V., Heralde, F. M., Chintalapani, G., Fowlkes, N. W., Huang, S. Y., & Melancon, M. P. (2025). Mesenchymal Stem Cells Loaded in Injectable Alginate Hydrogels Promote Liver Growth and Attenuate Liver Fibrosis in Cirrhotic Rats. Gels. https://doi.org/10.3390/gels11040250

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.